Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-10-15
著者
-
OHNISHI Kazunori
Third Department of Internal Medicine, Hamamatsu University School of Medicine
-
OHNO Ryuzo
Aichi Cancer Center
-
TAKAHASHI Masatomo
Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School
-
EMI Nobuhiko
Department of Hematology, Fujita Health University
-
NAKAO Shinji
Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
FUJIMOTO MASAHIRO
First Department of Internal Medicine, Kansai Medical University
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
Tsunoda T
Laboratory For Medical Informatics Snp Research Center Riken (institute Of Physical And Chemical Res
-
HIRANO Masami
Department of Hematology, Fujita Health University School of Medicine
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
JINNAI Itsuro
Nagasaki CML Study Group
-
HIRAI Hisamaru
Department of Hematology and Oncology, Graduate School of Medicine
-
TAUCHI Tetsuzo
First Department of Internal Medicine (Division of Hematology), Tokyo Medical University
-
Takahashi Masatomo
Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O
-
Takahashi Masatomo
聖マリアンナ医科大学 血液･腫瘍内科
-
Yokozawa Toshiya
豊橋市民病院 血液･腫瘍内科
-
Yokozawa Toshiya
Clinical Research Center National Hospital Organization Nagoya Medical Center
-
Yokozawa T
Hematology Division National Cancer Center Hospital
-
Yokozawa Toshiya
Department Of Hematology Nagoya University Graduate School Of Medicine
-
Yokozawa Toshiya
Division Of Hematology Nagoya Medical Center
-
Jinnai Itsuro
長崎大学医学部歯学部附属病院 輸血部
-
Ohno R
Aichi Cancer Center
-
Ohno Ryuzo
琉球大学 医学部血液免疫検査学分野
-
Tanimoto Mitsune
国立がんセンター中央病院 造血幹細胞移植グループ
-
Tanimoto Mitsune
Okayama Univ. Hospital Okayama Jpn
-
Ohnishi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
Jinnai Itsuro
International Medical Center Saitama Medical University
-
HIGASHIHARA Masaaki
Kitasato University Hospital
-
NAKAO Shinji
Kanazawa University Hospital
-
NISHIMURA Miki
Chiba University Hospital
-
TANII Hiromi
Novartis Pharma Japan
-
BESSHO Masami
Department of Hematology, Saitama Medical University, School of Medicine
-
NISHIMURA Miki
Second Department of Medicine, Chiba University School of Medicine
-
OGITA Masami
Sapporo National Hospital
-
TAGUCHI Hirokuni
Kochi Medical School
-
SHIMAZAKI Chihiro
Second Department of Medicine,Kyoto Prefectural University of Medicine
-
Minami H
Department Of Hematology Fujita Health University School Of Medicine
-
Higashihara Masaaki
あけぼの病院 内科
-
Higashihara Masaaki
北里大学 医学部第4内科(血液内科)
-
Taguchi Hirokuni
浜松医科大学 内科学第3
-
Shimazaki Chihiro
Second Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Shimazaki Chihiro
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Tomonaga Masao
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Tomonaga Masao
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Hirai Hisamaru
Department Of Hematology And Oncology Graduate School Of Medicine
-
Tanimoto Mitsune
名古屋大学 第1内科
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Bessho Masami
Department Of Hematology Saitama Medical University School Of Medicine
-
Bessho Masami
Department Of Hematology Saitama Medical University
-
Nishimura Miki
Chiba Univ. Hospital Chiba Jpn
-
Oguchi Masahiko
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
CHIBA Shigeru
Department of Cell Therapy & Transplantation Medicine University of Tokyo Hospital
-
TAGUCHI Hirokuni
Department of Hematology and Respiratory Medicine, Kochi University School of Medicine
-
MIZOGUCHI Hideaki
Department of Hematology, Tokyo Women's Medical College
-
KAWAI Yasukazu
First Department of Internal Medicine, Fukui Medical University
-
YAZAKI Fumiharu
Department of Hematology, Saitama Medical School
-
URABE Akio
Department of Hematology, NTT Kanto Medical Center
-
JINNAI Itsuro
Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Bios
-
Tomonaga Masao
Department Of Hematology Atomic Bomb Disease Institute Nagasaki University School Of Medicine
-
Sahara Naohi
浜松医科大学 内科学第3
-
Nakamura Satoki
県西部浜松医療センター 血液科
-
Hirano Masami
Department Of Internal Medicine Division Of Hematology And Medical Oncology Fujita Health University
-
Kawai Yasukazu
Divison Of Hematology & Oncology University Of Fukui Hospital
-
Chiba Shigeru
Department Of Cell Therapy And Transplantation Medicine University Of Tokyo Hospital
-
Shirafuji Naoki
Department Of Hematology Kanazawa University
-
Emi Nobuhiko
First Department Of Internal Medicine Nagoya University Graduate School Of Medicine
-
Emi Nobuhiko
The First Department Of Internal Medicine Nagoya University School Of Medicine
-
Emi Norihiko
Department Of Hematology Fujita Health University
-
SHIMAZAKI Chihiro
Kyoto Prefecture University of Medicine
-
Ogita Masami
Graduate School Of Electronic Science And Technology Shizuoka University
-
Tanii Hiromi
Novartis Pharma K.k.
-
Nishimura Miki
Second Department Of Internal Medicine Chiba University School Of Medicine
-
Taniwaki Masafumi
Third Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Taniwaki Masafumi
Department Of Molecular Hematology And Oncology Kyoto Prefectural University Of Medicine Graduate Sc
-
Nakao Shinji
Department Of Hematology Kanazawa University Graduate School Of Medical Science
-
Ohnishi Kazunori
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Minami Hironobu
Oncology/hematology National Cancer Center Hospital East
-
Fujimoto Masahiro
First Department Of Internal Medicine
-
Jinnai Itsuro
Division Of Hematology Department Of Internal Medicine Saitama Medical School
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Disease Institute Nagasaki University Gradua
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Yagasaki Fumiharu
Department Of Hematology Saitama Medical University Hospital
-
Hirano Masami
Department Of Hematology Fujita Health University School Of Medicine
-
Taguchi Hirokuni
Department Of Internal Medicine Kochi Medical School
-
Hirai Hisamaru
Department Of Hematology And Oncology Faculty Of Medicine University Of Tokyo
-
Hirai Hisamaru
Department Of Cell Therapy And Transplantation University Of Tokyo
-
Ogura M
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Nakao Shinji
Third Department Of Medicine Kanazawa University
-
URABE Akio
Division of Hematology, NTT Kanto Medical Center
-
Ohno Ryuzo
Department Of Medicine Iii Hamamatsu Medical School
-
Ogura Michinori
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Nakao Shinji
Cellular Transplantation Biology Department Of Respiratory Medicine Kanazawa University Graduate Sch
-
Taguchi Hirokuni
Department Of Diagnostic Pathology Kochi Red Cross Hospital
-
Moriuchi Yukiyoshi
Nagasaki Cml Study Group Nagasaki Jpn
-
Hirano Masami
Kitasato University Hospital
-
Tsunoda Tatsuhiko
Laboratory For Medical Informatics Snp Research Center Riken (institute Of Physical And Chemical Res
-
Fujimoto Masahiro
First Department Of Internal Medicine Kansai Medical University
-
Shimazaki C
Kyoto Prefecture University Of Medicine
-
Tsunoda Takeshi
Laboratory For Medical Informatics Snp Research Center Riken (institute Of Physical And Chemical Res
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Kawai Yasukazu
First Department Of Internal Medicine Faculty Of Medical Sciences University Of Fukui
-
Tauchi Tetsuzo
First Department Of Internal Medicine (division Of Hematology) Tokyo Medical University
-
Yokozawa Toshiya
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Urabe A
Ntt Kanto Medical Center
-
Tanimoto Mitsune
Okayama Univ. Graduate School Of Medicine Okayama Jpn
-
Mizoguchi Hideaki
Department Of Hematology Tokyo Women's Mdical University
-
Mizoguchi Hideaki
Department Of Hematology Tokyo Women's Medical University School Of Medicine
-
Emi N
Department Of Hematology Nagoya University Graduate School Of Medicine
-
Shirafuji Naoki
Department Of Hematology/oncology Teikyo University School Of Medicine
-
Jinnai Itsuro
Department Of Health Evaluation Ogawa Red Cross Hospital
-
Emi Nobuhiko
Department Of Hematology And Clinical Oncology Fujita Health University School Of Medicine
-
Chiba Shigeru
Department Of Hematology/oncology And Cell Therapy/transplantation Medicine University Of Tokyo Hosp
-
Yagasaki Fumiharu
Department Of Public Health Shimane University Faculty Of Medicine
-
Fujita Yasuyuki
Department Of Public Health Shimane University Faculty Of Medicine
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Expression of annexin II in experimental abdominal aortic aneurysms
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Cord blood transplantation using minimum conditioning regimens for patients with hematologic malignancies complicated by severe infections
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Ischemic heart disease associated with bortezomib treatment combined with dexamethasone in a patient with multiple myeloma
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome-wide cDNA Microarray Analysis
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Case-control study of leukemia and diagnostic radiation exposure
- Successful cord blood transplantation for mycosis fungoides.
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication
- Two Cases of Acute Promyelocytic Leukemia Complicated by Torsade de Pointes during Arsenic Trioxide Therapy
- Two Patients with All-trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Treated Successfully with Gemtuzumab Ozogamicin as a Single Agent
- Delayed Recovery of Normal Hematopoiesis in Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia: A Comparison to All-trans Retinoic Acid Treatment
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma
- International Consensus Conference on Bone Marrow Failure Syndromes : Review and Recommendations
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Anti-moesin antibodies derived from patients with aplastic anemia stimulate monocytic cells to secrete TNF-α through an ERK1/2-dependent pathway
- A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
- High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
- Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
- Hydroxyurea upregulates NKG2D ligand expression in myeloid leukemia cells synergistically with valproic acid and potentially enhances susceptibility of leukemic cells to natural killer cell-mediated cytolysis
- Persistent Remission after Immunosuppressive Therapy of Hairy Cell Leukemia Mimicking Aplastic Anemia : Two Case Reports
- Effect of a tyrosine kinase inhibitor STI571 in a patient with hepatic metastases from a duodenal gastrointestinal stromal tumor
- Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia
- A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients
- Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
- Unrelated Donor Marrow Transplantation for Congenital Immunodeficiency and Metabolic Disease : An Update of the Experience of the Japan Marrow Donor Program
- Cyclosporin therapy for acquired aplastic anemia: Predictive factors for the response and long-term prognosis
- Clinical significance of a small population of paroxysmal nocturnal hemoglobinuria-type cells in the management of bone marrow failure
- Effects of KF19514, a Phosphodiesterase 4 and 1 Inhibitor, on Bronchial Inflammation and Remodeling in a Murine Model of Chronic Asthma
- Mesenchymal Stem Cells Isolated from Frozen Bone Marrow Have Multilineage Potency
- Complete and durable remission of refractory mantle cell lymphoma with repeated rituximab monotherapy
- Current trends in the management of malignant lymphoma: new WHO classification, guidelines for high-dose therapy with HSCT, and new response criteria
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Genetic Diagnosis of Community-Acquired MRSA: A Multiplex Real-Time PCR Method for Staphylococcal Cassette Chromosome mec Typing and Detecting Toxin Genes
- How High Can We Increase Complete Remission Rate in Adult Acute Myeloid Leukemia?
- 4 Activity of the Science Council of Japan Aiming for Tobacco-free Society in Japan(The 6th Anti-Smoking Promotion Seminar, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Myelodysplastic syndrome
- Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Treatment of chronic myeloid leukemia with imatinib mesylate
- Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors
- High dose Chemotherapy and Stem Cell Support in a Patient of Light- and Heavy-chain Deposition Disease with Abnormal Marrow Cell Surface Antigens and No Monoclonal protein
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma : a single institute experience
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- IgG4-Related Disease : A Novel Lymphoproliferative Disorder Discovered and Established in Japan in the 21st Century
- Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis
- Clinical Features of Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus in a Tertiary Hospital
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Mismatched human leukocyte antigen class II-restricted CD8^+ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- IgG4-related disease : Historical overview and pathology of hematological disorders
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
- Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- In vivo efficacy of doripenem (DRPM) against Pseudomonas aeruginosa in murine chronic respiratory tract infection model.
- Clinical Characteristics of Seven Patients with Aeromonas Septicemia in a Japanese Hospital
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
- A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study